You have 9 free searches left this month | for more free features.

Luspatercept

Showing 26 - 38 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

Completed
  • Erythrocyte Transfusion
  • Beta-Thalassemia
  • Luspatercept
  • Placebo
  • Los Angeles, California
  • +72 more
Jan 21, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
  • Myelodysplastic Syndromes
  • Luspatercept
  • Placebo
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS (MDS), Beta-thalassemia, Myeloproliferative Tumor(MPN)-Associated Myelofibrosis Trial in Worldwide (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Luspatercept
  • Los Angeles, California
  • +203 more
Jan 30, 2023

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

Minimisation Measures for REBLOZYL Among Healthcare

Active, not recruiting
  • Myelodysplastic Syndromes
  • Beta-thalassemia
    • City, State, Austria
      Local Institution
    Aug 4, 2022

    Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)

    Completed
    • Transfusion-dependent Beta-Thalassemia
    • Peshawar, Khyber Pakhtunkhwa, Pakistan
      Blood Care Clinic
    Nov 19, 2023

    Low Risk MDS Trial (R906289 Monosodium (R289 Na))

    Not yet recruiting
    • Low Risk Myelodysplastic Syndromes
    • R906289 Monosodium (R289 Na)
    • (no location specified)
    Jul 22, 2022

    Myeloproliferative Tumor Trial in New York (Vactosertib)

    Recruiting
    • Myeloproliferative Neoplasm
    • New York, New York
      Weill Medical College of Cornell University
    Dec 20, 2021

    GENOMED4ALL: Improving MDS Classification and Prognosis by AI

    Active, not recruiting
    • Myelodysplastic Syndromes
      • Milano, Italy
        Istituto Clinico Humanitas
      Jun 28, 2021

      l Research in Myelodysplastic Syndromes

      Recruiting
      • Myelodysplastic Syndromes
        • Paris, France
        • +3 more
        Nov 20, 2019

        B-Thalassemia Trial in Greece, Italy (ACE-536)

        Completed
        • B-Thalassemia
        • Athens, Greece
        • +7 more
        Dec 13, 2016

        Anemia Trial in Tempe (ACE-536, Placebo)

        Completed
        • Anemia
        • ACE-536
        • Placebo
        • Tempe, Arizona
          Acceleron Investigative Site
        Nov 5, 2012